Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00715247 · ClinicalTrials.gov registry record
Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 726
- Enrollment target
NCT00715247: Completed study, sponsored by University of Utah.
NCT00715247 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 726 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00715247 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 726 participants
- Enrollment target
Study Summary
The purpose of this project is to find genes whose mutations cause Polycythemia Vera, Essential Thrombocythemia and Primary Myelofibrosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 726 participants |
| Start Date | 2006-07 |
| Est. Completion | 2018-12 |
What the finished NCT00715247 record still lists
NCT00715247 is an observational study that tracks outcomes without assigning an intervention. The registered 726 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00715247 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00715247 about?
NCT00715247 is a clinical study titled "Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes". The purpose of this project is to find genes whose mutations cause Polycythemia Vera, Essential Thrombocythemia and Primary Myelofibrosis.
What is the current status of trial NCT00715247?
This trial is currently completed. The enrollment target is 726 participants. The study started on 2006-07. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT00715247?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06731478 · 726 participants · Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- NCT05634967 · 725 participants
Kesimpta (Ofatumumab) Pregnancy Registry
- NCT05065216 · 728 participants · Phase 2
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
- NCT05739123 · 728 participants
Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia